Jaguar animal health to host treatment forum for veterinarians about chemotherapy-induced diarrhea (cid) in dogs on sunday, january 16th during the veterinary meeting & expo (vmx) conference in orlando, florida

Canalevia™-ca1, which received conditional approval from the fda on december 21, 2021, is the first and only treatment for cid in dogs to receive any type of approval from fda u.s. veterinarians, veterinary oncologists, and members of the media can click here to register for the cid treatment forum; remote access will be available to participants unable to attend in person san francisco, ca / accesswire / january 12, 2022 / jaguar health, inc. (nasdaq:jagx), under its jaguar animal health tradename for the veterinary market, today announced that the company is hosting a treatment forum for veterinarians about chemotherapy-induced diarrhea (cid) in dogs on sunday, january 16 from 6 p.m. - 8 p.m. eastern during the veterinary meeting & expo (vmx) conference in orlando, florida.
JAGX Ratings Summary
JAGX Quant Ranking